← Back to Search

Frailty Prevention Program to Prevent Frailty Among Older African Americans (FPP Trial)

N/A
Waitlist Available
Led By Heather Fritz, PhD
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from week 0 to week 40
Awards & highlights
No Placebo-Only Group

Summary

Between 20-60% of older adults experience frailty as they age. Frailty is a clinical state of increased vulnerability resulting from aging-associated declines in biological reserve across multiple physiologic systems. Because of the lack of biological reserve, relatively minor physical or psychological assaults have the potential to trigger a cascade of negative sequelae for frail older adults resulting in adverse health outcomes including mortality, disability in basic and instrumental activities of daily living, hospitalization and emergency visits, and institutionalization in community-dwelling older adults. Despite the potential personal and economic consequences of frailty syndrome, frailty is not an irreversible process. For example, a 4.5-year longitudinal study conducted by Gill et al., (2006) demonstrated that of their 754 community dwelling older adults, 58% had at least one change in frailty status during the study period and that approximately one third of these transitions were from a state of greater frailty to one of lesser frailty, suggesting that it is possible to reverse the frailty trajectory. Nonetheless, there is a lack effective means of reversing frailty or slowing the progression of older adults along the frailty continuum.The purpose of the proposed research is to evaluate the feasibility and preliminary effectiveness of an occupational therapy intervention delivered through the primary care setting for improving frailty status and physical functioning among older adults ages 55 and older who are pre-frail when compared to usual care.

Eligible Conditions
  • Frailty Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from week 0 to week 40
This trial's timeline: 3 weeks for screening, Varies for treatment, and from week 0 to week 40 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Frailty
Habit formation
Secondary study objectives
Global Health
Health Service Utilization
Self Rate Quality of Life
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Frailty Prevention ProgramExperimental Treatment1 Intervention
4 face-to-face sessions, with a licensed and registered occupational therapist over 4 months
Group II: Educational materialsActive Control1 Intervention
Participants receive publicly available educational materials
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Frailty Prevention Program
2018
N/A
~60

Find a Location

Who is running the clinical trial?

Michigan Health Endowment FundUNKNOWN
4 Previous Clinical Trials
530 Total Patients Enrolled
Wayne State UniversityLead Sponsor
314 Previous Clinical Trials
110,837 Total Patients Enrolled
Heather Fritz, PhDPrincipal InvestigatorWayne State University
3 Previous Clinical Trials
77 Total Patients Enrolled
~8 spots leftby Dec 2025